Outcome of critically ill patients with hematological malignancies

Annals of Hematology

Volumn 92, Issue 5, 2013, Pages 699-705

  Ñamendys Silva, Silvio A ^a,b   González Herrera, María O ^a   García Guillén, Francisco J ^a   Texcocano Becerra, Julia ^a   Herrera Gómez, Angel ^a  

^a INSTITUTO NACIONAL DE CANCEROLOGÍA   (Mexico)

^b INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

Author keywords

Critical care; Critically ill patients; Hematological malignancies; Intensive care unit; Outcomes

Indexed keywords

CREATININE; HYPERTENSIVE FACTOR;

ADULT; ARTICLE; ARTIFICIAL VENTILATION; CANCER PROGNOSIS; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CRITICALLY ILL PATIENT; FEMALE; HEMATOLOGIC MALIGNANCY; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEXICO; MORTALITY; MULTIPLE ORGAN FAILURE; NEUTROPENIA; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY;

ADULT; ALGORITHMS; COHORT STUDIES; CRITICAL ILLNESS; FEMALE; HEMATOLOGIC NEOPLASMS; HOSPITAL MORTALITY; HUMANS; INTENSIVE CARE UNITS; MALE; MEXICO; MIDDLE AGED; PRACTICE GUIDELINES AS TOPIC; PROGNOSIS; RESPIRATION, ARTIFICIAL;

EID: 84877894175     PISSN: 09395555     EISSN: 14320584     Source Type: Journal    
DOI: 10.1007/s00277-013-1675-7     Document Type: Article

References (30)

1. Coiffier B, Lepage E, Briere J et al (2002) CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med 346(4):235-242
2. O'Brien SG, Guilhot F, Larson RA et al (2003) Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia. N Engl J Med 348(11):994-1004
3. Bird GT, Farquhar-Smith P, Wigmore T, Potter M, Gruber PC (2012) Outcomes and prognostic factors in patients with haematological malignancy admitted to a specialist cancer intensive care unit: a 5 yr study. Br J Anaesth 108(3):452-459
4. Geerse DA, Span LF, Pinto-Sietsma SJ, van Mook WN (2011) Prognosis of patients with haematological malignancies admitted to the intensive care unit: Sequential Organ Failure Assessment (SOFA) trend is a powerful predictor of mortality. Eur J Intern Med 22(1):57-61
5. Taccone FS, Artigas AA, Sprung CL, Moreno R, Sakr Y, Vincent JL (2009) Characteristics and outcomes of cancer patients in European ICUs. Crit Care 13(1):R15
6. Massion PB, Dive AM, Doyen C et al (2002) Prognosis of hematologic malignancies does not predict intensive care unit mortality. Crit Care Med 30(10):2260-2270
7. Scales DC, Thiruchelvam D, Kiss A, Sibbald WJ, Redelmeier DA (2008) Intensive care outcomes in bone marrow transplant recipients: a population-based cohort analysis. Crit Care 12(3):R77
8. Owczuk R, Wujtewicz MA, Sawicka W, Wadrzyk A, Wujtewicz M (2005) Patients with haematological malignancies requiring invasive mechanical ventilation: differences between survivors and non-survivors in intensive care unit. Support Care Cancer 13(5):332-338
9. Hampshire PA, Welch CA, McCrossan LA, Francis K, Harrison DA (2009) Admission factors associated with hospital mortality in patients with haematological malignancy admitted to UK adult, general critical care units: a secondary analysis of the ICNARC Case Mix Programme Database. Crit Care 13(4):R137
10. Namendys-Silva SA, Texcocano-Becerra J, Herrera-Gómez A (2010) Prognostic factors in critically ill patients with solid tumor admitted to an oncological intensive care unit. Anaesth Intensiv Care 38:317-324
11. Ñamendys-Silva SA, González-Herrera MO, Texcocano-Becerra J, Herrera-Gómez A (2011) Clinical characteristics and outcomes of critically ill cancer patients with septic shock. QJM 104(6):505-511
12. Thiéry G, Azoulay E, Darmon M et al (2005) Outcome of cancer patients considered for intensive care unit admission: a hospital-wide prospective study. J Clin Oncol 23:4406-4413
13. Lecuyer L, Chevret S, Thiery G, Darmon M, Schlemmer B, Azoulay E (2007) The ICU trial: a new admission policy for cancer patients requiring mechanical ventilation. Crit Care Med 35:808-814
14. Oken MM, Creech RH, Tormey DC et al (1982) Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5(6):649-655
15. Knaus WA, Draper EA, Wagner DP, Zimmerman JE (1985) APACHE II: a severity of disease classification system. Crit Care Med 13(10):818-829
16. Vincent JL, Moreno R, Takala J et al (1996) The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure: on behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 22(7):707-710
17. Le Gall JR, Lemeshow S, Saulnier F (1993) A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 270(24):2957-2963
18. Bone RC, Balk RA, Cerra FB et al (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 101(6):1644-1655
19. Kuehnhardt D, Hannemann M, Schmidt B, Heider U, Possinger K, Eucker J (2009) Therapeutic implication of BAL in patients with neutropenia. Ann Hematol 88(12):1249-1256
20. Dellinger RP, Levy MM, Carlet JM et al (2008) Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 36:296-327
21. Hanley JA, McNeil BJ (1982) The meaning and use of the area under receiver operating characteristic (ROC) curve. Radiology 143(1):29-36
22. Hosmer DW, Taber S, Lemeshow S (1991) The importance of assessing the fit of logistic regression models: a case study. Am J Public Health 81(12):1630-1635
23. Lamia B, Hellot MF, Girault C et al (2006) Changes in severity and organ failure scores as prognostic factors in onco-hematological malignancy patients admitted to the ICU. Intensive Care Med 32(10):1560-1568
24. Khassawneh BY, White P Jr, Anaissie EJ, Barlogie B, Hiller FC (2002) Outcome from mechanical ventilation after autologous peripheral blood stem cell transplantation. Chest 121(1):185-188
25. Depuydt PO, Benoit DD, Roosens CD, Offner FC, Noens LA, Decruyenaere JM (2010) The impact of the initial ventilatory strategy on survival in hematological patients with acute hypoxemic respiratory failure. J Crit Care 25(1):30-36
26. Soares M, Salluh JI, Carvalho MS, Darmon M, Rocco JR, Spector N (2006) Prognosis of critically ill patients with cancer and acute renal dysfunction. J Clin Oncol 24(24):4003-4010
27. Maccariello E, Valente C, Nogueira L et al (2011) Outcomes of cancer and non-cancer patients with acute kidney injury and need of renal replacement therapy admitted to general intensive care units. Nephrol Dial Transplant 26(2):537-543
28. Cornet AD, Issa AI, van de Loosdrecht AA et al (2005) Sequential organ failure predicts mortality of patients with a haematological malignancy needing intensive care. Eur J Haematol 74(6):511-516
29. Peigne V, Rusinová K, Karlin L et al (2009) Continued survival gains in recent years among critically ill myeloma patients. Intensive Care Med 35(3):512-518
30. Legrand M, Max A, Peigne V et al (2012) Survival in neutropenic patients with severe sepsis or septic shock. Crit Care Med 40(1):43-49